http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018100219-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
filingDate 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e1e5c2d55084d6d13ee15b5554d7ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db98c156bf78f732cc4ce56e845f80e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f5a93244ab75881abb71aa9883b151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a45d6c2052b48becde3dee2eb7adf864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460427c0bea3e5783a5f31f397f575d4
publicationDate 2018-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018100219-A1
titleOfInvention Silylated derivatives of reservatrol and the use thereof in neurodegenerative, neurological or inflammatory diseases
abstract The invention relates to a group of compounds derived from reservatrol, comprising at least one silyl group as substituents, which in turn can be substituted with different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological and neurodegenerative diseases.
priorityDate 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011073482-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134571171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID374837356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134571167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID374837360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433197

Total number of triples: 42.